Curis Inc (CRIS.O)

CRIS.O on Consolidated Issue listed on NASDAQ Global Market

30 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for CRIS.O


Curis, Inc. is a drug discovery and development company that is committed to leveraging signaling pathway drug technologies in seeking to develop next generation network-targeted cancer therapies. The Company conducts its research and development programs both internally and through strategic collaborations. Its advanced program... (more)


Beta: 2.24
Market Cap (Mil.): $112.67
Shares Outstanding (Mil.): 86.00
Dividend: --
Yield (%): --


  CRIS.O Industry Sector
P/E (TTM): -- 170.49 34.41
EPS (TTM): -0.16 -- --
ROI: -21.33 -1.91 17.37
ROE: -37.48 -7.10 18.18
Search Stocks

BUZZ-U.S. Stocks on the Move-Coach, Corinthian, Curis, Integrys

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter,; for the Morning News Call newsletter,

23 Jun 2014

BUZZ -Curis Inc: Partner Roche seeks approval to start lung drug trial

** Says drug development partner Roche Holding AG filed for an U.S. regulatory approval to start mid-stage trial on their lung disease drug

23 Jun 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: New Constructs, LLC
Provider: S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks